OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antisense therapies in neurological diseases
J.-B. Brunet de Courssou, Alexandra Dürr, David Adams, et al.
Brain (2021) Vol. 145, Iss. 3, pp. 816-831
Open Access | Times Cited: 15
J.-B. Brunet de Courssou, Alexandra Dürr, David Adams, et al.
Brain (2021) Vol. 145, Iss. 3, pp. 816-831
Open Access | Times Cited: 15
Showing 15 citing articles:
Tofersen: First Approval
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 11, pp. 1039-1043
Closed Access | Times Cited: 85
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 11, pp. 1039-1043
Closed Access | Times Cited: 85
Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology
Man Amanat, Christina L. Nemeth, Amena Smith Fine, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2389-2389
Open Access | Times Cited: 43
Man Amanat, Christina L. Nemeth, Amena Smith Fine, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2389-2389
Open Access | Times Cited: 43
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases
Jacob Helm, Lüdger Schöls, Stefan Hauser
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1708-1708
Open Access | Times Cited: 34
Jacob Helm, Lüdger Schöls, Stefan Hauser
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1708-1708
Open Access | Times Cited: 34
Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies
Asra Nasir Khan, Rizwan Hasan Khan
International Journal of Biological Macromolecules (2022) Vol. 223, pp. 143-160
Closed Access | Times Cited: 26
Asra Nasir Khan, Rizwan Hasan Khan
International Journal of Biological Macromolecules (2022) Vol. 223, pp. 143-160
Closed Access | Times Cited: 26
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1690-1720
Closed Access | Times Cited: 23
Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1690-1720
Closed Access | Times Cited: 23
Current potential therapeutics of amyotrophic lateral sclerosis
Lijun Lu, Youqing Deng, Renshi Xu
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Lijun Lu, Youqing Deng, Renshi Xu
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
mRNA Degradation as a Therapeutic Solution for Mucopolysaccharidosis Type IIIC: Use of Antisense Oligonucleotides to Promote Downregulation of Heparan Sulfate Synthesis
Juliana Inês Santos, Mariana Gonçalves, Matilde Barbosa Almeida, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1273-1273
Open Access
Juliana Inês Santos, Mariana Gonçalves, Matilde Barbosa Almeida, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1273-1273
Open Access
Artificial intelligence in diabetes management: transformative potential, challenges, and opportunities in healthcare
Arnabjyoti Deva Sarma, Moitrayee Devi
HORMONES (2025)
Closed Access
Arnabjyoti Deva Sarma, Moitrayee Devi
HORMONES (2025)
Closed Access
The Pathobiology of Cerebrovascular Lesions in CADASIL Small Vessel Disease
Anne Joutel
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 5
Open Access
Anne Joutel
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 5
Open Access
Phenotypic complexities of rare heterozygous neurexin-1 deletions
Michael B. Fernando, Yu Fan, Yanchun Zhang, et al.
Nature (2025)
Closed Access
Michael B. Fernando, Yu Fan, Yanchun Zhang, et al.
Nature (2025)
Closed Access
A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31
Janya Grainok, Ianthe Pitout, Fred K. Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3391-3391
Open Access | Times Cited: 3
Janya Grainok, Ianthe Pitout, Fred K. Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3391-3391
Open Access | Times Cited: 3
Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 7
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 7
Precise Therapeutic Targeting of DistinctNRXN1+/-Mutations
Michael B. Fernando, Yu Fan, Yanchun Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Michael B. Fernando, Yu Fan, Yanchun Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Advances in targeting neurotransmitter systems in dystonia
Dora Steel, Kimberley M. Reid, Antonio Pisani, et al.
International review of neurobiology (2023), pp. 217-258
Closed Access | Times Cited: 3
Dora Steel, Kimberley M. Reid, Antonio Pisani, et al.
International review of neurobiology (2023), pp. 217-258
Closed Access | Times Cited: 3
Awake intracerebroventricular delivery and safety assessment of oligonucleotides in a large animal model
Hector Ribeiro Benatti, Rachel Prestigiacomo, Toloo Taghian, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101122-101122
Open Access
Hector Ribeiro Benatti, Rachel Prestigiacomo, Toloo Taghian, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101122-101122
Open Access
